Last updated: 11/07/2018 17:08:01
A Double-Blind, Double-Dummy, Randomized, Parallel Group Comparison of 200mcg Fluticasone Propionate Aqueous Nasal Spray, Placebo and 10mg Encapsulated Loratadine Administered (No More than Once Daily) As-Needed in Subjects with Seasonal Allergic Rhinitis
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A Double-Blind, Double-Dummy, Randomized, Parallel Group Comparison of 200mcg Fluticasone Propionate Aqueous Nasal Spray, Placebo and 10mg Encapsulated Loratadine Administered (No More than Once Daily) As-Needed in Subjects with Seasonal Allergic Rhinitis
Trial description: A Double-Blind, Double-Dummy, Randomized, Parallel Group Comparison of 200mcg Fluticasone Propionate Aqueous Nasal Spray, Placebo and 10mg Encapsulated Loratadine Administered (No More than Once Daily) As-Needed in Subjects with Seasonal Allergic Rhinitis
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Abstract: Analysis of medication use in a prn study of seasonal allergic rhinitis. HB Kaiser CK Cook ST Goode-Sellers BA Prillaman LA Witham EE Philpot 58th Annual Meeting of the American Academy of Allergy, Asthma and Immunology 3/1/2002 New York, NY; USA
Abstract: Fluticasone propionate aqueous nasal spray provides greater improvement than placebo in the symptoms of rhinitis when used as-needed (prn). Frank C Hampel B T Bock ST Goode-Sellersg LA Witham CK Cook: Y E Philpot 58th Annual Meeting of the American Academy of Allergy, Asthma and Immunology 3/1/2002 New York, NY; USA
Dykewicz MS, Kaiser H, Schenkel EJ, Stoloff RS, Goode-Sellers ST, Witham LA, Cook CK, Philpot EE. Fluticasone propionate aqueous nasal spray improves nasal symptoms of rhinitis when used as-needed (PRN). Ann Allergy Asthma Immunol 2003;91:44-48 Kaiser HB, Allergy and Asthma Specialists, P.A., Cook CK, Goode-Sellers ST, Prillaman BA, Witham LA, Philpot EE,. Analysis of Medication Use in a PRN Study of Seasonal Allergic Rhinitis. J Allergy Clin Immunol, 2002;109(1):S104 (abstract)
Medical condition
Rhinitis, Allergic, Seasonal
Product
fluticasone propionate
Collaborators
Not applicable
Study date(s)
August 2000 to October 2000
Type
Not applicable
Phase
4
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2000-19-10
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website